Gunnar Wieboldt

Gunnar Wieboldt brings nearly 20 years of legal experience to StrideBio in mostly entrepreneurial and life science roles. Mr. Wieboldt served as Division Counsel at ZOLL Medical, a cardiac medical device company, and most recently as Head of Global Contracts at Thermo Fisher Scientific’s Pharma Services Group where he led a team that negotiated the commercial contracts for a $4B division of Thermo Fisher including for Brammer Bio’s gene therapy contract manufacturing business.

A former USMC officer, Mr. Wieboldt earned his law degree from Harvard Law School, his MBA from Fuqua School of Business at Duke University (Health Sector Management), and his undergraduate degrees in English Literature and Political Science from the University of Rochester.